Month: January 2023

PHOENIX, Jan. 31, 2023 (GLOBE NEWSWIRE) — WillScot Mobile Mini Holdings Corp. (“WillScot Mobile Mini” or the “Company”) (Nasdaq: WSC) today announced it will release its fourth quarter 2022 financial results on Tuesday, February 21, 2023, after market close.

Chief Executive Officer Brad Soultz and President and Chief Financial Officer Tim Boswell will host a conference call and webcast on Wednesday, February 22, 2023, at 10 a.m. ET to discuss the results.

To access the live call by phone, use the following link: https://register.vevent.com/register/BI8f94abaee57f4f2ea09de369cf8b804a. You will be provided with dial-in details after registering. To avoid delays, we recommend that participants dial into the conference call 15 minutes ahead of the scheduled start time. A live webcast will also be accessible via the “Events & Presentations” section of the Company’s website www.willscotmobilemini.com. An archived version of the webcast will be available for 12 months following the call.

About WillScot Mobile Mini

WillScot Mobile Mini trades on the Nasdaq stock exchange under the ticker symbol “WSC.” Headquartered in Phoenix, Arizona, the Company is a leading business services provider specializing in innovative flexible workspace and portable storage solutions. WillScot Mobile Mini services diverse end markets across all sectors of the economy from a network of approximately 240 branch locations and additional drop lots throughout the United States, Canada, and Mexico.

Additional Information and Where to Find It

Additional information can be found on the company’s website at www.willscotmobilemini.com

Media Contact Information

Jake Saylor

jake.saylor@willscot.com

Investor Contact Information

Nick Girardi

nick.girardi@willscotmobilemini.com

GlobeNewswire Distribution ID 8739358

New York-based credit union to implement Nexus Engagement, Nexus Origination and Nexus Closing to modernize the member homebuying experience and gain process efficiencies

LEHI, Utah, Jan. 31, 2023 (GLOBE NEWSWIRE) — SimpleNexus (https://simplenexus.com/), an nCino (NASDAQ: NCNO) company and developer of the leading U.S. homeownership platform for loan officers, borrowers, real estate agents and settlement agents, announced today that AmeriCU will implement Nexus Engagement, Nexus Origination and Nexus Closing to provide a streamlined, mobile-first member experience.

Founded in 1950, AmeriCU is a member-owned, not-for-profit financial institution with more than 150,000 members and $2.4 billion in assets. AmeriCU’s mortgage loan originators help members achieve their financial goals by connecting them with conventional fixed-rate mortgages, adjustable-rate mortgages, jumbo loans, Veterans Administration (VA) loans, home equity loans, home equity lines of credit (HELOCs) and more.

“At AmeriCU, the satisfaction of our members is always our number one priority,” said Stephanie McGuire, senior vice president of lending at AmeriCU. “By equipping our mortgage teams with intelligent tools from SimpleNexus, they will be able to offer our members a more holistic homebuying experience and achieve unprecedented operational efficiency.”

Nexus Engagement helps lenders engage pre-application leads and strengthen referral strategies with real estate agents via a shareable mobile app featuring integrated tools such as homesearch listings and a payment calculator. Nexus Origination, SimpleNexus’ point-of-sale (POS) technology, enables borrowers to apply for a loan, submit documents, monitor loan status, contact their loan officer, electronically sign (eSign) disclosures and more. Nexus Closing is a comprehensive solution that supports traditional, hybrid and fully digital eClosings. Leveraging these tools together will enable AmeriCU to offer members a modern, single-sign-on experience via a mobile app while benefiting from the productivity advantages of streamlined workflows.

To maximize the process efficiencies of SimpleNexus, AmeriCU will activate SimpleNexus’ native integration with the credit union’s new loan origination system (LOS). Bi-directional data syncing between SimpleNexus and AmeriCU’s LOS will enable originators to enjoy simplified workflows. For instance, loan officers will have the ability to quickly generate and send disclosure documents directly from the SimpleNexus mobile app.

“SimpleNexus is a cost-effective resource for credit unions that want to offer members a more convenient and connected homebuying experience,” said Ben Miller, CEO of SimpleNexus. “Our mobile toolset, made stronger by native integrations and an open API framework, facilitates a state-of-the-art homebuying experience from point-of-thought to close.”

About SimpleNexus
SimpleNexus, an nCino (NASDAQ: NCNO) company, is an award-winning developer of mobile-first technology for the modern mortgage lender. U.S. lenders depend on our namesake homeownership platform to unite the people, systems and stages of the mortgage process into a seamless, end-to-end solution that spans engagement, origination, closing and business intelligence. By helping lenders manage their teams and stay connected with borrowers and real estate professionals, we deliver a measurable return on investment in the form of reduced turn times, increased loan application submissions and more referral business. A four-time Inc. 5000 company, SimpleNexus has been recognized as one of the world’s Best Workplaces for Innovators. For more information, visit https://www.simplenexus.com or follow @SimpleNexus.

About AmeriCU

As a credit union, AmeriCU is a not-for-profit financial institution owned by our members. Serving nine counties in Central and Northern New York, AmeriCU provides you with all the products and services you need – often with low or no fees, and better rates. The organization has been serving the local community for over 70 years and, in that time, has grown to more than 160,000 members, 20 locations, and $2.4 billion in assets. AmeriCU is located in Central New York and is among the State’s largest, full-service financial cooperatives. For more information, visit https://www.americu.org/.

Media Contacts
Leslie Colley
DepthPR for SimpleNexus
+1 678.622.6229
leslie@depthpr.com

David Bolin
SimpleNexus
+1 414.688.6077
dbolin@simplenexus.com

Safe Harbor Statement
This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally include actions, events, results, strategies and expectations and are often identifiable by use of the words “believes,” “expects,” “intends,” “anticipates,” “plans,” “seeks,” “estimates,” “projects,” “may,” “will,” “could,” “might,” or “continues” or similar expressions. Any forward-looking statements contained in this press release are based upon nCino’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent nCino’s expectations as of the date of this press release. Subsequent events may cause these expectations to change and, except as may be required by law, nCino does not undertake any obligation to update or revise these forward-looking statements. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially including, among others, risks and uncertainties relating to the market adoption of our solution and privacy and data security matters. Additional risks and uncertainties that could affect nCino’s business and financial results are included in reports filed by nCino with the U.S. Securities and Exchange Commission (available on our web site at www.ncino.com or the SEC’s web site at www.sec.gov). Further information on potential risks that could affect actual results will be included in other filings nCino makes with the SEC from time to time.

GlobeNewswire Distribution ID 8739424

The approval allows Eyenuk’s AI eye screening system, already approved for detection of diabetic retinopathy, to aid millions of additional patients at risk for vision loss

LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) — Eyenuk, a global artificial intelligence (AI) digital health company, and the leader in real-world applications for AI Eye Screening and AI Predictive Biomarkers, has been approved to market its EyeArt® AI eye screening system in the European Union for the new uses of detecting age-related macular degeneration (AMD) and glaucomatous optic nerve damage (a sign of glaucoma).

The EyeArt AI system (version 3.0) has been granted a new European Commission (EC) certification as a Class IIb medical device under the EU’s Medical Devices Regulation 2017/745 (“MDR”) and is intended to detect signs of diabetic retinopathy (DR) (including diabetic macular edema), AMD, and glaucomatous optic nerve damage in patients at risk of vision loss using computerized analysis of images of the retina. The EyeArt AI system was previously approved in the EU for the detection of DR including diabetic macular edema.

This EC Certification makes the EyeArt AI system the first and only autonomous AI solution with Class IIb MDR CE marking for the automated detection of all three eye diseases and will allow Eyenuk customers in the EU to detect the diseases in a single exam using the same set of retinal images. The EyeArt AI system is also the first and only system that is both CE Marked for the detection of the three diseases as well as FDA-cleared in the United States for the detection of DR, the leading cause of blindness among working-age adults.

The EyeArt AI system greatly expands the availability of vision-saving eye screenings by making automated AI diagnosis and coordination of care possible in primary care medical practices without the need for a specialist’s review. The system is integrated with retinal imaging cameras and can be operated by clinical support staff to generate a detailed screening report in less than 30 seconds. In regions with limited access to ophthalmologists, its ability to detect multiple eye diseases with a single exam can help reduce vision loss from these blinding eye diseases.

Malavika Bhaskaranand, Head of Regulatory and Clinical Affairs at Eyenuk, commented, “Achieving MDR certification is a major milestone for Eyenuk and a result of our early adaptation to the more stringent requirements of the new regulation. It reaffirms the strong results from rigorous clinical validation of the EyeArt AI system.”

Kaushal Solanki, Chief Executive Officer and Founder of Eyenuk, commented, “This EC certification multiplies our impact in two ways. First, our autonomous AI can now help many more patients at risk of vision loss – the population at risk of AMD and glaucoma, particularly seniors, in addition to people with diabetes. Second, our AI system can now provide a more comprehensive report for each patient with detection results for three diseases compared to just one previously.”

Solanki continued, “DR, AMD, and glaucoma are all asymptomatic in their early stages. The high sensitivity of the EyeArt AI system, and its ability to be delivered without a specialist, makes it easier to catch the diseases early and to take preventative measures to protect the vision of these patients. We look forward to the opportunity to forge new partnerships with world-class hospitals and healthcare institutions in Europe to help preserve the eyesight of millions across the continent with these diseases.”

EC Certification Caps Year of Breakthroughs for Eyenuk

The EC Certification of the EyeArt AI system caps a year of significant clinical and business milestones for Eyenuk. The company’s accomplishments in 2022 included:

• Securing $26 million in a Series A financing round, bringing the company’s total funding to over $43 million
• Reaching the new milestone of 70,000 patients screened using the EyeArt AI system globally since its FDA clearance in August 2020, by far the most screenings by any FDA-cleared autonomous AI system
• Growing the number of locations using the EyeArt AI system to more than 200 in 18 countries and throughout the US
• Publication of a major peer-reviewed study finding that the EyeArt AI system is far more sensitive in identifying referable DR than dilated eye exams by ophthalmologists and retina specialists
• Winning Juniper Research’s Future Digital Health award for the “Best Digital Diagnostics Solution”
• Being named a finalist for the UCSF Digital Health Award

About Eyenuk, Inc.

Eyenuk, Inc. is a global artificial intelligence (AI) digital health company and the leader in real-world AI Eye Screening for autonomous disease detection and AI Predictive Biomarkers for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. Find Eyenuk online on its website, Twitter, Facebook, and LinkedIn.

About the EyeArt AI System

The EyeArt AI system provides fully autonomous screening for diabetic retinopathy (DR), age-related macular degeneration (AMD), and glaucomatous optic nerve damage, including retinal imaging, based on international clinical standards and immediate reporting, in a single office visit during a patient’s regular exam. Once the patient’s fundus images have been captured and submitted to the EyeArt AI System, the detection results are available in a PDF report in less than 30 seconds.

The EyeArt AI system was developed with funding from the U.S. National Institutes of Health and is validated by the U.K. National Health Service. The EyeArt AI system has CE marking as a class IIb medical device in the European Union under the EU’s Medical Devices Regulation 2017/745 (“MDR”) for the detection of DR, AMD, and glaucomatous optic nerve damage. Additionally, the system has U.S. Food and Drug Administration 510(k) clearance and a Health Canada license for autonomous detection of DR. It is designed to be General Data Protection Regulation (GDPR) and Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.

The EyeArt AI system is reimbursable by government and private payors in the U.S. under the Category 1 Current Procedural Terminology (CPT) code 92229.

Learn more about the EyeArt AI System by watching this video.

Media Inquiries:
Todd Stein
510-417-0612
Todd@toddsteincommunications.com

GlobeNewswire Distribution ID 8739343

CALGARY, Alberta, Jan. 31, 2023 (GLOBE NEWSWIRE) — Eavor Technologies Inc. (“Eavor”), a leader in globally scalable geothermal technology, is pleased to announce the successful completion of its next generation geothermal demonstration project in New Mexico, USA: Eavor-Deep.

Beginning in August and concluding in December of last year, after having drilled a two-leg multilateral well down to 18,000’ TVD and ~250°C, Eavor met its objectives, including achieving technical milestones which have drawn a follow-on investment of $10 million CAD from bp Ventures (“bp Ventures”).

These milestones were a combination of technical and operational measures and markers including depth, temperature, bit-life and rate of penetration in granite rock.

Several other objectives were reached including:

• Isolation of the upper fractured permeable zone with casing to enable drilling of the multilaterals in the deeper low permeability basement rock, and subsequent sealing with Rock-Pipe technology.
• Demonstrated insulated drill pipe (“IDP”) thermodynamic and mechanical performance with increased Rate of Penetration aided by shock cooling.
• Successfully executed cased hole side-track in granite.
• Demonstrated directional steering ability in hard rock with difficult intrusions and interbedded metamorphic formations.

Helmerich & Payne, Inc. (“H&P”) has also added to its 2021 equity investment, bringing its total to $10.2 million CAD, building on the companies’ ongoing collaborative efforts to further advance state of the art drilling technologies.

Mark Hodder, VP Drilling at Eavor, stated that: “The opportunity to confront this level of technical drilling challenges is rare. Our successes at Eavor-Deep are credited to the talents, commitment and passion of the combined teams of Eavor and H&P.”

Combined with the proof of concept demonstrated at the Derek Riddell Eavor-Lite Demonstration Facility near Rocky Mountain House, Alberta, Canada in 2019, the milestones reached at Eavor-Deep in 2022 have validated all the key elements required to construct and operate commercial Eavor-Loops.

Matt Toews, CTO at Eavor, stated that: “The goals for our technology include not only reaching sub US$60 per megawatt-hour costs, but to enable widespread global scalability. The progress made in New Mexico is a critical step in this endeavor, and alongside our partners we will continue this process of innovation and iteration.”

About Eavor Technologies Inc.

Eavor (pronounced “Ever”) is a technology-based energy company led by a team dedicated to creating a clean, reliable, and affordable energy future on a global scale. Eavor’s solution (Eavor-Loop®) represents the world’s first truly scalable form of clean, dispatchable, baseload capable, and flexible power. Eavor achieves this by mitigating or eliminating many of the issues that have traditionally hindered geothermal energy. Eavor instead circulates a benign working fluid that is completely isolated from the environment in a closed-loop, through a massive subsurface radiator. This radiator simply collects heat from the natural geothermal gradient of the Earth via conduction. Eavor has been supported by equity investments made by several leading global energy producers, investors, developers, and venture capital funds including Vickers Venture Partners, bp Ventures, BDC Capital, Temasek, Chevron Technology Ventures, BHP Ventures, Helmerich & Payne, Precision Drilling and Chubu Electric Power. info@eavor.com

About bp Ventures:

bp ventures was set up more than 10 years ago as bp’s corporate venture capital arm. Since then bp has invested over $1bn in technology companies and is actively managing 40 investments today. bp ventures makes strategic equity investments in private, high growth businesses accelerating innovation across bp’s transition growth engines: renewables, EV charging, convenience, bioenergy, and hydrogen. bp.com/ventures

About Helmerich & Payne, Inc.:

Founded in 1920, Helmerich & Payne, Inc. (H&P) (NYSE: HP) is committed to delivering industry leading levels of drilling productivity and reliability. H&P strives to operate with the highest level of integrity, safety and innovation to deliver superior results for its customers and returns for shareholders. Through its subsidiaries, the Company designs, fabricates and operates high-performance drilling rigs in conventional and unconventional plays around the world. H&P also develops and implements advanced automation, directional drilling and survey management technologies. www.helmerichpayne.com

Reference material: NREL – Techno-economic performance of Eavor-Loop 2.0 – Eavor

Contact Data

Eavor Technologies Inc.
John Redfern
President & CEO
John.Redfern@eavor.com
Tel: +1-650-269-2501

GlobeNewswire Distribution ID 8739450

TEMECULA, Calif., Jan. 30, 2023 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group (“Group”), a part of the Nikkiso Co., Ltd (Japan) group of companies, is proud to announce yet another expansion of their manufacturing and service capabilities for the Middle East and Northern Africa markets. With this expansion, they will be providing pump and turboexpander aftermarket repairs of their full line, including J.C. Carter pumps. Their new state-of-the-art service center will allow repairs to be made locally rather than the need to ship elsewhere.

The new facility, based in the Sharjah Free Zone, was established to provide expanded support for the Middle East and Northern Africa markets. They have added field service support, and shop technicians specifically trained to support Marine, J.C. Carter, Nikkiso Cryogenic Pumps (ACD and Nikkiso Cryo) and Turboexpanders. In addition to in-shop and on-site repairs, they will provide aftermarket service.

“With this facility, we will be able to respond more quickly to our customer’s needs, providing individual support and solutions expansion. Nikkiso CE&IG will now be able to provide greater service and support to our customers with our local presence,” according to Jim Estes, President of Nikkiso Cryogenic Services.

This expansion represents their commitment to and support of the growth of the Middle Eastern and North African market.

ABOUT CRYOGENIC INDUSTRIES
Cryogenic Industries, Inc. (now a member of Nikkiso Co., Ltd.) member companies manufacture and service engineered cryogenic gas processing equipment (pumps, turboexpanders, heat exchangers, etc.) and process plants for Industrial Gases, and Natural Gas Liquefaction (LNG), Hydrogen Liquefaction (LH2) and Organic Rankine Cycle for Waste Heat Recovery. Founded over 50 years ago, Cryogenic Industries is the parent company of ACD, Nikkiso Cryo, Nikkiso Integrated Cryogenic Solutions, Cosmodyne and Cryoquip and a commonly controlled group of 20 operating entities.

For more information, please visit www.nikkisoCEIG.com and www.nikkiso.com.

MEDIA CONTACT:
Anna Quigley
+1.951.383.3314
aquigley@cryoind.com

A photo accompanying this announcement is available at:
https://www.globenewswire.com/NewsRoom/AttachmentNg/a782646f-6550-4069-9f74-4f531a3eae7d

GlobeNewswire Distribution ID 8739306